{"id":"doi:10.1056/nejmoa1609243","kind":"article","title":"A Highly Durable RNAi Therapeutic Inhibitor of PCSK9","authors":["Kevin J. Fitzgerald","Suellen White","Anna Borodovsky","Brian R. Bettencourt","Andrew Louis Strahs","Valerie A. Clausen","Peter L. J. Wijngaard","Jay D. Horton","Jörg Täubel","Ashley Brooks","Chamikara Fernando","Robert S. Kauffman","David G. Kallend","Akshay K. Vaishnaw","Amy R. Simon"],"author_count":15,"year":2016,"published":"2016-11-13","venue":"New England Journal of Medicine","cited_by":768,"doi":"10.1056/nejmoa1609243","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa1609243","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa1609243","updated":null,"pmid":"27959715","pmcid":null,"openalex_id":"W2555483953","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1609243?articleTools=true","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}